Improving Real-Time PCR Assay Design for Better Clinical Diagnostics
Author Information
Author(s): Gordon H. Lemmon, Shea N. Gardner
Primary Institution: Vanderbilt University
Hypothesis
Current real-time PCR assay design methods produce signatures with low sensitivity for clinical applications.
Conclusion
Current methods for real-time PCR assay design have unacceptably low sensitivities for most clinical applications.
Supporting Evidence
- Many published signatures have high specificity but low sensitivity.
- New sequence data requires regular reassessment of old assays.
- A standard protocol for generating and assessing assay quality is valuable.
Takeaway
This study looked at how well real-time PCR tests work and found that many of them miss detecting infections. It suggests better ways to design these tests.
Methodology
The study analyzed 112 real-time PCR signatures from literature using public sequence data to predict their sensitivity and specificity.
Potential Biases
The study may not account for all variations in target organisms, leading to potential false negatives.
Limitations
The analysis is based on in silico predictions and not laboratory testing, which may not reflect actual performance.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website